Life Sciences

Researchers discovered that psoriasis patients have low-grade inflammation deep in their intestines, with half showing increased gut permeability. The finding suggests psoriasis may be a systemic disease affecting multiple organs, opening new treatment pathways and explaining why some patients develop gastrointestinal symptoms alongside skin problems.EN

Children treated for craniosynostosis—a condition requiring skull surgery—score lower on standardized tests in third grade, particularly in math and reading, according to Swedish registry data. The effect is strongest in girls and those with psychiatric conditions, raising questions about long-term developmental support needed after corrective surgery.EN

Women with Turner syndrome face nearly triple the mortality rate of matched peers, with aortic dissection accounting for almost a quarter of deaths. The Swedish study of 472 patients over 26 years reveals a specific, preventable cardiovascular vulnerability that could reshape screening and monitoring protocols for this population—and highlight gaps in rare disease clinical management.EN

Researchers have identified a distinctive pattern of right heart damage in patients with ATTR cardiac amyloidosis, a rare but serious inherited disease. The finding could help doctors diagnose the condition earlier and distinguish it from other heart disorders, potentially improving treatment decisions for a patient population that currently lacks targeted therapies.EN

Researchers have sequenced the genome of Hexamita inflata, a single-celled organism that reveals how parasites may have evolved from free-living ancestors. The discovery shows this free-living relative has a genome 10 times larger than parasitic cousins, offering clues that could inform drug development and our understanding of how pathogens adapt to infect hosts.EN

Researchers have mapped the molecular mechanics of how RNase P enzymes precisely cut RNA molecules, revealing that a single nucleotide position controls both where the cut happens and how efficiently. The discovery could accelerate development of RNA-based therapeutics and improve synthetic biology applications that rely on RNA processing.EN

A major review reveals that sex hormones fundamentally rewire immune responses, with testosterone suppressing certain defenses while estrogen enhances them. Gender-affirming hormone therapy offers researchers a rare window to study these shifts in real time—findings that could reshape treatment protocols for autoimmune diseases and inform how clinicians manage immune health across diverse populations.EN

Researchers used PET scanning to track neutrophil elastase—a destructive enzyme released during severe infection—in sepsis patients for the first time. The findings could help doctors pinpoint which patients need enzyme-blocking drugs, potentially reshaping sepsis treatment decisions worth billions annually in critical care.EN

Researchers argue that chronic pain treatments designed from group data fail individual patients whose pain works differently. The solution: personalized treatment protocols based on each person's unique psychological patterns. For healthcare systems and insurers, this could mean better outcomes and lower costs by ditching generic approaches.EN

Researchers used a cholera toxin component as an immune adjuvant to strengthen cancer vaccines against melanoma and breast cancer spread in mice. The advance could accelerate development of therapies targeting the metastatic cancers responsible for roughly 90% of cancer deaths—a significant commercial opportunity for vaccine manufacturers and oncology biotech firms.EN

Researchers have discovered that traumatic brain injury causes amyloid buildup in brain blood vessels within hours, mirroring early Alzheimer's pathology. The finding could reshape how clinicians monitor TBI patients and develop preventive therapies for neurodegenerative disease—a major opportunity for pharmaceutical and diagnostic companies.EN

Researchers have identified that AA amyloidosis, a serious systemic disease, exists in at least two genetically distinct forms that affect the body differently. The finding could reshape how doctors diagnose and treat the condition, and suggests a decades-old theory about infectious disease variants applies to more common illnesses than previously thought.EN

Swedish researchers identified protein markers in urine that predict disease severity and progression in IgA nephropathy, a leading cause of kidney failure worldwide. The findings could enable earlier intervention and better patient stratification, potentially reducing costly dialysis and transplant procedures.EN

Scientists discovered that a missing immune receptor called ST2 makes aggressive brain tumors spread faster and resist treatment. The finding, based on mouse models and patient tumor samples, identifies a potential therapeutic target that could improve survival rates for glioblastoma, a cancer with dismal 5-year survival odds.EN

Researchers analyzing 536 infants found that genetics influences how long babies fixate on faces and objects—but different genes are at work depending on whether they're viewing realistic social scenes or abstract patterns. The finding suggests that eye-tracking metrics, increasingly used to screen for developmental disorders, may need context-specific interpretation to be clinically useful.EN

Researchers have created a lab-based screening system using neural cells to detect how endocrine-disrupting chemicals harm fetal brain development. The advance could help regulators and manufacturers identify dangerous substances before they reach consumers, potentially reducing liability and improving chemical safety standards across industries.EN

Researchers have developed a faster way to map vibrations and magnetic movements within materials using electron microscopes. The breakthrough could accelerate development of new semiconductors, quantum devices, and advanced materials by giving engineers detailed snapshots of how atoms actually behave inside their products.EN

Newly approved drugs for drug-resistant bacteria hit the market with significant gaps in clinical evidence, leaving hospitals uncertain about prescribing guidelines. The study reveals that reimbursement systems and treatment protocols remain poorly defined, threatening the effectiveness of medicines that took years to develop and regulatory approval.EN

Pharmaceutical companies are increasingly using computational models that simultaneously track tumor size, drug side effects, and patient survival to accelerate oncology drug development. The approach allows drugmakers to test dosing strategies and identify patient subgroups more efficiently, potentially cutting development timelines and reducing failed trials.EN

Scientists have identified how a bacterial protein called ProQ shields harmful RNA from destruction, enabling pathogens like Salmonella to cause infection. The discovery reveals a potential drug target: blocking this protection mechanism could disable bacteria's ability to form biofilms and survive inside host cells, offering a pathway for developing antibiotics that work differently than current treatments.EN

Researchers studying isolated monkey populations in West Africa found genetic blueprints for surviving drastic population declines—insights that could reshape conservation strategy and wildlife management. The findings matter as species globally face similar bottlenecks from habitat loss, offering a roadmap for preserving endangered animals and maintaining genetic diversity in small populations.EN

Researchers studying decision-making in rats discovered that how quickly animals master a gambling test doesn't predict their later betting strategies. The finding challenges assumptions used in preclinical drug testing and could reshape how scientists design studies to screen psychiatric and neurological treatments.EN

Researchers identified a genetic variant in the BACE2 gene that influences colorectal cancer susceptibility and tumor characteristics in Swedish patients. The finding could refine risk stratification for screening programs and inform treatment selection, potentially improving outcomes for the 1.9 million people diagnosed with colorectal cancer globally each year.EN

Researchers propose a new framework for studying protein interactions by examining how evolution has shaped binding mechanisms across thousands of organisms. The approach could accelerate drug discovery and protein engineering by revealing design principles that evolution has already tested and refined over millions of years.EN

Scientists have identified multiple compounds that can bind to SMYD3, an enzyme involved in cancer development, at a site different from where most drugs attack. By screening existing commercial chemicals rather than synthesizing new ones, the approach could accelerate drug development while reducing the risk of unwanted side effects from hitting related enzymes.EN